Pure Bioscience (PURE) Stock Price & Overview
NASDAQ:PURE
Current stock price
The current stock price of PURE is 0.37 null. Today PURE is down by -15.91%. In the past month the price decreased by -36.21%. In the past year, price increased by 48%.
PURE Key Statistics
- Market Cap
- 23.203M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.08
- Dividend Yield
- N/A
PURE Stock Performance
PURE Stock Chart
PURE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to PURE. When comparing the yearly performance of all stocks, PURE is a bad performer in the overall market: 61.08% of all stocks are doing better.
PURE Earnings
PURE Forecast & Estimates
PURE Financial Highlights
Over the last trailing twelve months PURE reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 27.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -277.17% | ||
| ROA | -74.9% | ||
| ROE | -125.22% | ||
| Debt/Equity | 0 |
PURE Ownership
About PURE
Company Profile
PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including methicillin-resistant Staphylococcus aureus (MRSA), or staph infection. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of `green` products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.
Company Info
Pure Bioscience
1725 GILLESPIE WAY
EL CAJON CA 92020
CEO: Henry R. Lambert
Phone: 619-596-8600
Pure Bioscience / PURE FAQ
What does PURE do?
PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including methicillin-resistant Staphylococcus aureus (MRSA), or staph infection. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of `green` products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.
Can you provide the latest stock price for Pure Bioscience?
The current stock price of PURE is 0.37 null. The price decreased by -15.91% in the last trading session.
What is the dividend status of Pure Bioscience?
PURE does not pay a dividend.
What is the ChartMill rating of Pure Bioscience stock?
PURE has a ChartMill Technical rating of 0 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
What is Pure Bioscience worth?
Pure Bioscience (PURE) has a market capitalization of 23.20M null. This makes PURE a Nano Cap stock.
What is the outstanding short interest for Pure Bioscience?
The outstanding short interest for Pure Bioscience (PURE) is 0.01% of its float.